Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists
Yong Gong(Johnson & Johnson (United States)), Wei He(Hebei Medical University), Pamela J. Hornby(Springhouse), Guy Van Lommen, J. Van Wauwe, Concha Claes, Jian Li(Huaian First People’s Hospital), J. Kent Barbay(Johnson & Johnson (United States)), Mieke Buntinx
Cited by 19
Related Papers
The pharmacology and therapeutic applications of monoclonal antibodies
|Pharmacology Research & Perspectives|2019|346
<i>C</i>-Glycosidation Technology With Free Radical Reactions
|Synlett|1998|151
Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women
|Frontiers in Cellular and Infection Microbiology|2019|150
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
|British Journal of Pharmacology|2012|121